<DOC>
	<DOCNO>NCT00004332</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether release endogenous growth hormone ( GH ) -releasing hormone involve GH response clonidine , pyridostigmine , levodopa , arginine , GH-releasing peptide , insulin-induced hypoglycemia , exercise patient acromegaly . II . Determine whether endogenous GH-releasing hormone influence maintenance GH hypersecretion .</brief_summary>
	<brief_title>Study Effect Growth Hormone-Releasing Hormone Antagonist Growth Hormone Release Acromegaly</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Growth hormone-releasing hormone antagonist ( GHRH-A ) administer volunteer follow 1 challenge : insulin , clonidine , pyridostigmine , arginine , levodopa , growth hormone-releasing peptide , exercise . Tests repeat normal saline control ; order administration ( control vs. pharmacologic stimulation ) randomly assign . Patients receive GHRH-A ( dose determine volunteer study ) , thyrotropin-releasing hormone , growth-releasing hormone . All stimulation test follow overnight fast .</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Hormone Antagonists</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Active acromegaly growth hormone ( GH ) hypersecretion confirm within 1 month prior entry , i.e . : Somatomedin C elevate GH 2 ng/mL standard 100 g oral glucose tolerance test Postmenopausal hypogonadal woman eligible Volunteers age 18 30 recruit 3 stimulation test Weight within 15 % ideal Physical exam normal No history disease No requirement medication No medical mental contraindication protocol participation , include heavy alcohol tobacco use No pregnant woman Prior/Concurrent Therapy Not specify Patient Characteristics Age : 18 65 Hematopoietic : No anemia Hepatic : No hepatic disease Renal : No renal disease Cardiovascular : No uncontrolled hypertension No heart disease Other : No requirement replacement gonadal steroid , glucocorticoid , thyroxine No mental illness No heavy alcohol use No tobacco use No drug abuse No medical contraindication protocol therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>acromegaly</keyword>
	<keyword>endocrine disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>